Cite
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
MLA
Croxford, S., et al. “Preliminary Indications of the Burden of COVID-19 among People Who Inject Drugs in England and Northern Ireland and the Impact on Access to Health and Harm Reduction Services.” Public Health (Elsevier), vol. 192, Mar. 2021, pp. 8–11. EBSCOhost, https://doi.org/10.1016/j.puhe.2021.01.004.
APA
Croxford, S., Emanuel, E., Ibitoye, A., Njoroge, J., Edmundson, C., Bardsley, M., Heinsbroek, E., Hope, V., & Phipps, E. (2021). Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services. Public Health (Elsevier), 192, 8–11. https://doi.org/10.1016/j.puhe.2021.01.004
Chicago
Croxford, S., E. Emanuel, A. Ibitoye, J. Njoroge, C. Edmundson, M. Bardsley, E. Heinsbroek, V. Hope, and E. Phipps. 2021. “Preliminary Indications of the Burden of COVID-19 among People Who Inject Drugs in England and Northern Ireland and the Impact on Access to Health and Harm Reduction Services.” Public Health (Elsevier) 192 (March): 8–11. doi:10.1016/j.puhe.2021.01.004.